Patent application number | Description | Published |
20110061625 | EXHAUST THROTTLE-EGR VALVE MODULE FOR A DIESEL ENGINE - A valve assembly for use in an air management assembly having an engine, an exhaust side, and an intake side, where the valve assembly provides a housing, a plurality of openings in the housing, a valve in the housing, and an actuator operably connected to the valve. The housing is in fluid communication with the exhaust side and the intake side. The plurality of openings in the housing form at least one inlet and at least one outlet in the housing. The valve moves with respect to the plurality of openings. | 03-17-2011 |
20110093182 | ESTIMATING ENGINE PARAMETERS BASED ON DYNAMIC PRESSURE READINGS - A method and system for estimating engine parameters in a combustion engine gas exchange system based on dynamic pressure readings taken by one or more pressure sensors. According to an exemplary embodiment, the method and system may use an artificial neural network (ANN) to process the dynamic pressure readings and any additional engine conditions that may have been provided. | 04-21-2011 |
20120330575 | ESTIMATING ENGINE SYSTEM PARAMETERS BASED ON ENGINE CYLINDER PRESSURE - A method includes sensing pressure within an engine cylinder, and estimating at least one other engine system parameter based on the sensed pressure. Another method includes designing an engine system, which includes one or more engine cylinder pressure sensors and one or more other engine system sensors. According to this method, the engine system is operated, and engine cylinder pressure is sensed using the engine cylinder pressure sensors, which are in communication with an engine cylinder of an engine of the engine system. Also, other engine system parameters are sensed to obtain at least one other engine system parameter using the other engine system sensors. The engine cylinder pressure is correlated to the at least one other engine system parameter, and engine cylinder pressure is used to replace or augment the at least one other engine system parameter that correlates to the engine cylinder pressure. | 12-27-2012 |
Patent application number | Description | Published |
20090000297 | Re-Introduction Unit for Lp-Egr Condensate At/Before the Compressor - The present invention is an exhaust gas recirculation system for a motor vehicle, having a turbocharger unit ( | 01-01-2009 |
20090013978 | Integrated Charge Air and Egr Valve - An engine assembly ( | 01-15-2009 |
20090071150 | Mixing Unit for LP-EGR Condensate Into the Compressor - The present invention is a an exhaust gas return system ( | 03-19-2009 |
20090178407 | ENHANCED ENGINE AIR BREATHING SYSTEM WITH AFTER TREATMENT DEVICE BEFORE THE TURBOCHARGER - A turbocharger arrangement providing a turbocharger, at least one treatment device, and at least one boost device. The turbocharger has a turbine and a compressor that are moveably coupled to one another. The turbine has an upstream path and a downstream path. The compressor has an upstream path and a downstream path. The at least one treatment device is in fluid communication with the upstream path of the turbine. The at least one additional boost device is operably engaged with the turbocharger to assist the flow of a gaseous fluid through the at least one treatment device and the turbocharger. | 07-16-2009 |
20100043761 | INTEGRATION OF AN EXHAUST AIR COOLER INTO A TURBOCHARGER - The present invention relates to a compressor-cooler module, having a housing, a compressor contained in the housing and an air cooler disposed within the housing and positioned in the flow path of the compressor. The present invention also includes an intake in fluid communication with the housing, a cooler bypass valve operably associated with the air cooler and the compressor, and a low-pressure exhaust gas recirculation passage operably associated with the cooler bypass valve, and the cooler by pass valve selectively directs exhaust gas to bypass the air cooler. | 02-25-2010 |
20100300088 | METHOD OF CONTROLLING A TURBOCHARGER - Another embodiment of the invention includes a method of controlling a turbocharger to achieve at least one of: produce air in excess of that required to operate a combustion engine at a specific power demand; control the flow of gas through the turbine; or control the turbine speed independent of boost pressure required to avoid specific speeds. | 12-02-2010 |
20110125361 | DIAGNOSING A COOLING SUBSYSTEM OF AN ENGINE SYSTEM IN RESPONSE TO DYNAMIC PRESSURE SENSED IN THE SUBSYSTEM - A method of diagnosing a cooling subsystem of an engine system in response a parameter extracted from dynamic hydraulic pressure sensed in the cooling subsystem, and products and systems using same. | 05-26-2011 |
20140283588 | DIAGNOSING A COOLING SUBSYSTEM OF AN ENGINE SYSTEM IN RESPONSE TO DYNAMIC PRESSURE SENSED IN THE SUBSYSTEM - A method of diagnosing a cooling subsystem of an engine system in response a parameter extracted from dynamic hydraulic pressure sensed in the cooling subsystem, and products and systems using same. | 09-25-2014 |
Patent application number | Description | Published |
20100125139 | PROCESS FOR PREPARING QUINAZOLINE RHO-KINASE INHIBITORS AND INTERMEDIATES THEREOF - A process for the preparation of various quinazoline compounds which are useful as Rho-Kinase inhibitors, and thus having utility in the treatment of hypertension and other indications. | 05-20-2010 |
20100137324 | RHO-KINASE INHIBITORS - Disclosed are compounds and derivatives thereof, their synthesis, and their use as Rho-kinase inhibitors. These compounds of the present invention are useful for inhibiting tumor growth, treating erectile dysfunction, and treating other indications mediated by Rho-kinase, e.g., coronary heart disease. | 06-03-2010 |
20100216789 | RHO-KINASE INHIBITORS - Disclosed are compounds and derivatives thereof, their synthesis, and their use as Rho-kinase inhibitors. These compounds of the present invention are useful for inhibiting tumor growth, treating erectile dysfunction, and treating other indications mediated by Rho-kinase, e.g., coronary heart disease. | 08-26-2010 |
Patent application number | Description | Published |
20080255068 | Chemical Compound and Its Use - The present application relates to a novel tetrahydroquinoline derivative, to a process for its preparation, to its use on its own or in combination for treating and/or preventing diseases and to its use for preparing medicaments, in particular as an inhibitor of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemias, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, hypercholesterolaemias and arteriosclerosis. | 10-16-2008 |
20090215743 | Tricyclic benzazepine derivatives and their use - The present application relates to novel tricyclic benzazepine derivatives, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of cardiovascular disorders, especially of dyslipidaemias, arteriosclerosis, restenosis and ischaemias. | 08-27-2009 |
20090306197 | Substituted Chromanol Derivatives and Their Use - The present invention relates to substituted chromanol derivatives, to processes for their preparation, to their use on their own or in combination for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders. | 12-10-2009 |
20100125073 | BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL IN THE TREATMENT OF CANCERS OF THE CENTRAL NERVOUS SYSTEM - The present invention relates to benzofuran and benzothiophene derivatives and compositions containing such compounds for the production of medicaments for the treatment of cancers of the central nervous system as monotherapy or combination with other agents. | 05-20-2010 |
20100129321 | DIARYL UREA FOR TREATING VIRUS INFECTIONS - The present invention relates to pharmaceutical compositions for treating virus infections and/or diseases caused thereby comprising 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide optionally combined with at least one additional therapeutic agent. | 05-27-2010 |
20100178293 | USE OF ANTIBODIES AGAINST THE CD52 ANTIGEN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS, PARTICULARLY TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY AND ALZHEIMER'S DISEASE - The present invention relates to the use of antibodies against the CD52 antigen, specifically monoclonal antibodies, for the production of medicaments for the treatment of diseases of the central nervous system, in particular transmissible spongiform encephalopathies, diseases that are also called prion diseases. | 07-15-2010 |
20110158942 | DIARYL UREAS FOR TREATING VIRUS INFECTIONS - The present invention relates to pharmaceutical compositions for treating virus infections and/or diseases caused by virus infections comprising at least a diaryl urea compound optionally combined with at least one additional therapeutic agent. Useful combinations include e.g. BAY 43-9006 as a diaryl urea compound. | 06-30-2011 |
20120009150 | DIARYL UREAS FOR TREATING VIRUS INFECTIONS - The present invention relates to pharmaceutical compositions for treating virus infections and/or diseases caused by virus infections comprising at least a diaryl urea compound optionally combined with at least one additional therapeutic agent. Useful combinations include e.g. BAY 43-9006 as a diaryl urea compound. | 01-12-2012 |
20120142728 | CHEMICAL COMPOUND AND ITS USE - The present application relates to a novel tetrahydroquinoline derivative, to a process for its preparation, to its use on its own or in combination for treating and/or preventing diseases and to its use for preparing medicaments, in particular as an inhibitor of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemias, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, hypercholesterolaemias and arteriosclerosis. | 06-07-2012 |